Scroll

Press Releases

Burcon Closes Non-Brokered Private Placement of Convertible Debentures for $9.5 Million

12/10/2019

Vancouver, British Columbia, December 10, 2019 — Burcon NutraScience Corporation (TSX: BU) (“Burcon” or the “Company”), a global technology leader in the development of plant-based proteins, is pleased to announce that it has closed its previously announced non-brokered private placement (see news releases of the Company dated November 25, 2019 and November 28, 2019) of…

Read more

Burcon Increases Previously Announced Non-Brokered Private Placement of Convertible Debentures to $9.5 Million

11/28/2019

Vancouver, British Columbia, November 28, 2019 — Burcon NutraScience Corporation (TSX: BU) (“Burcon” or the “Company”), a global technology leader in the development of plant-based proteins, is pleased to announce that, based on orders received, it has increased its previously announced non-brokered private placement (see news release of the Company dated November 25, 2019) of…

Read more

Burcon Announces Non-Brokered Private Placement of Convertible Debentures

11/25/2019

Vancouver, British Columbia, November 25, 2019 — Burcon NutraScience Corporation (TSX: BU) (“Burcon” or the “Company”), a global technology leader in the development of plant-based proteins, is pleased to announce a non-brokered private placement of convertible debentures (the “Convertible Debentures”) for an aggregate principal amount of up to $4 million (the “Offering”).  Insiders of the…

Read more

Peazazz and Peazac Pea Proteins FDA GRAS Notified

10/21/2019

Vancouver, British Columbia, October 21, 2019 — Burcon NutraScience Corporation (TSX: BU), a global technology leader in the development of plant-based proteins, is pleased to announce today that the US Food and Drug Administration (“FDA”) has issued a GRAS (Generally Recognized As Safe) no-objection letter for Peazazz® and Peazac® pea proteins.  The “Letter of No…

Read more

Burcon Announces Results of Shareholder Meeting

09/18/2019

Vancouver, British Columbia, September 18, 2019 — Burcon NutraScience Corporation (TSX: BU) a global technology leader in the development of plant-based proteins, is pleased to announce the results from its 2019 annual meeting of shareholders (the “Meeting”) held on September 17, 2019.  All of the seven nominees set out in Burcon’s management proxy circular dated…

Read more

Burcon Updates on Development Activities

09/17/2019

Vancouver, British Columbia, September 17, 2019 — Burcon NutraScience Corporation (TSX: BU), a global technology leader in the development of plant-based proteins, is pleased to provide an update of its recent development activities.  Burcon and its partners have now funded their full share of the capital contributions to Merit Functional Foods Corporation (“Merit Foods” or…

Read more

Burcon Receives Notice of Allowance from the United States Patent Office for Peazazz Pea Protein Patent

08/21/2019

 Vancouver, British Columbia, August 21, 2019 — Burcon NutraScience Corporation (TSX: BU), a global technology leader in the development of plant-based proteins, announced today that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application covering certain valuable attributes of Burcon’s Peazazz® pea protein.  A notice…

Read more